The outlook for the life sciences sector is robust heading into the final months of 2024, according to Knight Frank, thanks to growing venture capital investment.
By the end of September this year, the number of active UK life sciences
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
